Literature DB >> 14762780

Independent influences of body mass and gastric volumes on satiation in humans.

Silvia Delgado-Aros1, Filippo Cremonini, Janet E Castillo, Heather J Chial, Duane D Burton, Irene Ferber, Michael Camilleri.   

Abstract

BACKGROUND & AIMS: We assessed the association of body mass and gastric volumes (fasting and postprandial) with satiation and postprandial symptoms.
METHODS: Healthy obese and nonobese subjects underwent measurement of caloric intake at maximum satiation; postprandial symptoms were measured with visual analogue scales 30 minutes after a meal. Gastric volume during fasting and after 300 mL of Ensure was measured with technetium-99m single-photon emission computed tomography imaging. We used multiple regression analysis to assess the associations among variables.
RESULTS: Among 134 participants (81 women and 53 men), the median age was 26 years (range, 12-58 years), and the median body mass index was 24 kg/m(2) (range, 17-48 kg/m(2)). Increased body mass index, but not height, was associated with delayed satiation (P < 0.003, adjusted for sex). Overweight and obese subjects ingested, on average, 225 +/- 57 more kilocalories (945 +/- 239 kJ) at maximum satiation compared with normal weight individuals. Increased fasting gastric volume was not associated with body mass index or height, but it was significantly associated with delayed satiation (P = 0.001, adjusted for body mass index and sex). An increase of 50 mL in the fasting gastric volume was associated with 114 +/- 32 kcal (479 +/- 134 kJ) more ingested at maximum satiation. Increased body mass index was associated with lower fullness scores 30 minutes after a meal (P = 0.0012, adjusted for sex and volume of Ensure ingested). In contrast, scores of postprandial bloating and pain were higher with increased body mass index (both P < 0.05, adjusted for sex and volume of Ensure ingested).
CONCLUSIONS: Greater body mass index and fasting gastric volume are associated with reduced satiation. Increased body mass index or height was not associated with greater gastric volumes.

Entities:  

Mesh:

Year:  2004        PMID: 14762780     DOI: 10.1053/j.gastro.2003.11.007

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  47 in total

1.  Obesity and gastrointestinal sensory-motor function.

Authors:  G Anton Decker; Michael D Crowell
Journal:  Curr Treat Options Gastroenterol       Date:  2005-08

2.  Fundal dysaccommodation in functional dyspepsia: head-to-head comparison between the barostat and three-dimensional ultrasonographic technique.

Authors:  M W Mundt; M Samsom
Journal:  Gut       Date:  2006-01-26       Impact factor: 23.059

3.  Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study.

Authors:  Mark Topazian; Michael Camilleri; Jose De La Mora-Levy; Felicity B Enders; Amy E Foxx-Orenstein; Michael J Levy; Vandana Nehra; Nicholas J Talley
Journal:  Obes Surg       Date:  2008-02-20       Impact factor: 4.129

Review 4.  Gastrointestinal Complications of Obesity.

Authors:  Michael Camilleri; Harmeet Malhi; Andres Acosta
Journal:  Gastroenterology       Date:  2017-02-10       Impact factor: 22.682

5.  Association of melanocortin 4 receptor gene variation with satiation and gastric emptying in overweight and obese adults.

Authors:  Andres Acosta; Michael Camilleri; Andrea Shin; Paula Carlson; Duane Burton; Jessica O'Neill; Deborah Eckert; Alan R Zinsmeister
Journal:  Genes Nutr       Date:  2014-01-24       Impact factor: 5.523

6.  Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy.

Authors:  Andres Acosta; Michael Camilleri; Andrea Shin; Maria I Vazquez-Roque; Johanna Iturrino; Duane Burton; Jessica O'Neill; Deborah Eckert; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2014-12-06       Impact factor: 22.682

7.  Body weight in patients with idiopathic gastroparesis.

Authors:  Henry P Parkman; Mark Van Natta; Goro Yamada; Madhusudan Grover; Richard W McCallum; Irene Sarosiek; Gianrico Farrugia; Kenneth L Koch; Thomas L Abell; Braden Kuo; Laura Miriel; James Tonascia; Frank Hamilton; Pankaj J Pasricha
Journal:  Neurogastroenterol Motil       Date:  2020-09-15       Impact factor: 3.598

8.  Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight.

Authors:  Mark Topazian; Michael Camilleri; Felicity T Enders; Jonathan E Clain; Ferga C Gleeson; Michael J Levy; Elizabeth Rajan; Vandana Nehra; Ross A Dierkhising; Maria L Collazo-Clavell; Nicholas J Talley; Matthew M Clark
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-09       Impact factor: 11.382

Review 9.  Nonnutritive sweetener consumption in humans: effects on appetite and food intake and their putative mechanisms.

Authors:  Richard D Mattes; Barry M Popkin
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

10.  Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial.

Authors:  Henry P Parkman; Mark L Van Natta; Thomas L Abell; Richard W McCallum; Irene Sarosiek; Linda Nguyen; William J Snape; Kenneth L Koch; William L Hasler; Gianrico Farrugia; Linda Lee; Aynur Unalp-Arida; James Tonascia; Frank Hamilton; Pankaj J Pasricha
Journal:  JAMA       Date:  2013-12-25       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.